Steven Ferris

Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open‐label, single‐arm, multicenter clinical study

Vjera Holthoff, Frank Tennigkeit, Serge Gauthier, 2013, International journal of geriatric psychiatry.

Memantine in moderate-to-severe Alzheimer's disease.

Rachelle Doody, B. Reisberg, F. Schmitt, 2003, The New England journal of medicine.

Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease.

James S Babb, Jens H Jensen, Joseph A Helpern, 2013, Magnetic resonance imaging.

Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice

Frank Tennigkeit, Serge Gauthier, Kati Sternberg, 2011, Alzheimer's Research & Therapy.

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review

Yaakov Stern, Rebecca Amariglio, R. Sperling, 2013, Alzheimer's Research & Therapy.

Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?

Frank Tennigkeit, Serge Gauthier, Philippe Robert, 2010, Alzheimer's Research & Therapy.

Hippocampal Atrophy Disrupts Transfer Generalization in Nondemented Elderly

Mony J de Leon, James Golomb, M. Gluck, 2002, Journal of geriatric psychiatry and neurology.

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.

John Seibyl, Vladimir Coric, Hilkka Soininen, 2015, JAMA neurology.